The methylation of the promoter region of the secreted frizzled-related protein 1 (SFRP1) holds potential as a diagnostic indicator and therapeutic target, particularly in specific malignancies like ampullary adenocarcinoma and gastric cancer, where its upregulation is linked to poor prognoses [88,89]. This evidence concerns the gene FRZB and ampulla of vater adenocarcinoma.